TransMedics Group Inc is a medical devices business based in the US. TransMedics Group shares (TMDX) are listed on the NASDAQ and all prices are listed in US Dollars. TransMedics Group employs 110 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in TransMedics Group
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TMDX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
TransMedics Group stock price (NASDAQ: TMDX)Use our graph to track the performance of TMDX stocks over time.
TransMedics Group shares at a glance
|Latest market close||$27.03|
|52-week range||$11.51 - $49.50|
|50-day moving average||$29.98|
|200-day moving average||$28.94|
|Wall St. target price||$46.40|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.10|
Buy TransMedics Group shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy TransMedics Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
TransMedics Group price performance over time
|1 week (2021-10-19)||-0.15%|
|1 month (2021-09-27)||-13.39%|
|3 months (2021-07-27)||-6.21%|
|6 months (2021-04-27)||-7.62%|
|1 year (2020-10-26)||110.84%|
|2 years (2019-10-25)||51.43%|
|3 years (2018-10-23)||N/A|
|5 years (2016-10-23)||N/A|
TransMedics Group financials
|Revenue TTM||$29.9 million|
|Gross profit TTM||$16.6 million|
|Return on assets TTM||-11.07%|
|Return on equity TTM||-29.58%|
|Market capitalisation||$759.5 million|
TTM: trailing 12 months
Shorting TransMedics Group shares
There are currently 936,930 TransMedics Group shares held short by investors – that's known as TransMedics Group's "short interest". This figure is 8.4% down from 1.0 million last month.
There are a few different ways that this level of interest in shorting TransMedics Group shares can be evaluated.
TransMedics Group's "short interest ratio" (SIR)
TransMedics Group's "short interest ratio" (SIR) is the quantity of TransMedics Group shares currently shorted divided by the average quantity of TransMedics Group shares traded daily (recently around 223078.57142857). TransMedics Group's SIR currently stands at 4.2. In other words for every 100,000 TransMedics Group shares traded daily on the market, roughly 4200 shares are currently held short.
However TransMedics Group's short interest can also be evaluated against the total number of TransMedics Group shares, or, against the total number of tradable TransMedics Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TransMedics Group's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 TransMedics Group shares in existence, roughly 30 shares are currently held short) or 0.0433% of the tradable shares (for every 100,000 tradable TransMedics Group shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against TransMedics Group.
Find out more about how you can short TransMedics Group stock.
TransMedics Group share dividends
We're not expecting TransMedics Group to pay a dividend over the next 12 months.
TransMedics Group share price volatility
Over the last 12 months, TransMedics Group's shares have ranged in value from as little as $11.51 up to $49.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TransMedics Group's is 1.9057. This would suggest that TransMedics Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TransMedics Group overview
TransMedics Group, Inc. , a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts. .
TransMedics Group in the news
TransMedics to Report Third Quarter 2021 Financial Results on November 9, 2021
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Could Be 48% Below Their Intrinsic Value Estimate
TransMedics price target raised to $30 from $29 at JPMorgan
Frequently asked questionsWhat percentage of TransMedics Group is owned by insiders or institutions?
Currently 6.984% of TransMedics Group shares are held by insiders and 70.485% by institutions. How many people work for TransMedics Group?
Latest data suggests 110 work at TransMedics Group. When does the fiscal year end for TransMedics Group?
TransMedics Group's fiscal year ends in December. Where is TransMedics Group based?
TransMedics Group's address is: 200 Minuteman Road, Andover, MA, United States, 01810 What is TransMedics Group's ISIN number?
TransMedics Group's international securities identification number is: US89377M1099 What is TransMedics Group's CUSIP number?
TransMedics Group's Committee on Uniform Securities Identification Procedures number is: 89377M109
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert